<DOC>
	<DOCNO>NCT00324974</DOCNO>
	<brief_summary>The purpose study assess safety efficacy lansoprazole microgranules oral suspension , daily ( QD ) , infant gastroesophageal reflux symptom 4-week treatment period .</brief_summary>
	<brief_title>The Use Lansoprazole Treat Infants With Symptoms Gastroesophageal Reflux</brief_title>
	<detailed_description>This study conduct approximately 20 investigative site U.S. Poland . Participants qualify randomize equal proportion receive either lansoprazole Pediatric Suspension ( 0.2-0.3 mg/kg/day infant &lt; 10 week age 1.0-1.5 mg/kg/day infant &gt; 10 week age ) Placebo . This study consist three period : Pretreatment Period 7-14 day , Double-Blind Treatment Period 4 week ( Dosing ) , Post-Treatment Period 30 day ( Follow-Up ) .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<criteria>At least 7 day postsurgery time Screening ( Study Visit 1 ) anticipate need surgery study . Experiencing symptom gastroesophageal reflux disease ( regurgitation , vomit `` spitting , '' fussing/irritability , feed refusal , cry feeding , arch back , poor weight gain , extraesophageal manifestation ) endoscopy proven reflux disease . Must continue reflux symptom Pretreatment Period despite reduce eliminate exposure tobacco smoke , use one position feed strategy last 7 day document Daily Diary . The infant exhibit cry , fussing , irritability within 1 hour feed &gt; 25 % feeding last 4 day Pretreatment Period document Daily Diary . Body weight &lt; 2.0 kilogram Dosing Day 1 DoubleBlind Treatment Period . Unstable , congenital acquire , clinically significant disease major organ system ( cardiovascular , respiratory , renal , hepatic , metabolic , etc . ) , include suspect and/or document cultureproven sepsis . Coexisting esophageal disease ( e.g. , eosinophilic esophagitis , viral , bacterial fungal infection ) caustic physiochemical trauma esophagus . Any congenital anomaly upper gastric intestinal tract might interfere gastrointestinal motility , pH , absorption , active know history necrotizing enterocolitis surgically correct . Use proton pump inhibitor within 30 day prior Dosing Day 1 . Use H2 Blockers ( i.e . Zantac ) within 7 day prior Dosing Day 1 . Allergy proton pump inhibitor ( i.e . Prilosec , Prevacid ) . Use prokinetics ( e.g. , metoclopramide ) unless stable dose least 3 day prior enter Pretreatment Period . Unable obtain stable drug level continuous treatment require drug include theophylline derivative , digoxin , phenytoin , phenobarbital , carbamazepine within 7 day prior Dosing Day 1 . Clinically Significant abnormalities clinical laboratory value .</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>11 Months</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Gastroesophageal Reflux Disease</keyword>
	<keyword>infant</keyword>
	<keyword>lansoprazole oral suspension</keyword>
	<keyword>PPI</keyword>
</DOC>